UK Court Rejects Challenge to Paediatric Extension of SPC for Lipitor

On 20 December 2012, the Patents Court of England and Wales rejected a challenge brought by Dr. Reddy's Laboratories against the six month paediatric extension of the Supplementary Protection Certificate (SPC) for Pfizer's cholesterol-lowering product atorvastatin (Lipitor). This is the first judgment on a challenge to a paediatric extension under the Paediatric Regulation.